Treatment of Recurrent Ovarian Cancer
1 clinical trials · Condition
◉ Watch Treatment of Recurrent Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer (NCT07286240) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2025-11-15 |
Track Treatment of Recurrent Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.